93338-62-6

Basic information

• Product Name: 3-aminobenzylguanidine
• Synonyms: 3-aminobenzylguanidine
• CAS NO: 93338-62-6
• Molecular Formula: C₈H₁₂N₄
• Molecular Weight: 0
• Mol File: 93338-62-6.mol

Chemical Properties

• Boiling Point: 383.5°Cat760mmHg
• Flash Point: 185.7°C
• Appearance: /
• Density: 1.28g/cm³
• Vapor Pressure: 4.37E-06mmHg at 25°C
• Refractive Index: 1.633
• CAS DataBase Reference: 3-aminobenzylguanidine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-aminobenzylguanidine(93338-62-6)
• EPA Substance Registry System: 3-aminobenzylguanidine(93338-62-6)

Safety Data

• Hazardous Substances Data: 93338-62-6(Hazardous Substances Data)

Usage

InChI:InChI=1/C8H12N4/c9-7-3-1-2-6(4-7)5-12-8(10)11/h1-4H,5,9H2,(H4,10,11,12)

Upstream product

• 93338-63-7 m-Nitrobenzylguanidine 

Relevant articles and documents

A new targeting agent for the selective drug delivery of nanocarriers for treating neuroblastoma

Novel targeting agents against neuroblastoma based on the meta-iodobenzylguanidine (MIBG) moiety were synthesized and biologically evaluated for nanocarrier vectorization. These compounds have been anchored on the surface of drug loaded mesoporous silica nanocarriers, resulting in the improved cellular uptake in tumoral cells. Neuroblastoma (NB) is the most frequent extracranial pediatric tumor. Advanced forms of the disease (metastatic and/or refractory) have a dismal prognosis despite the combination of chemotherapy, radiotherapy, surgery and bone narrow transplants. These treatments carry severe side effects and, in some cases, compromise the life of the patient. MIBG has been widely applied in the medical diagnosis of NB due to its affinity for tumor cells through the norepinephrine transporter (NET), which is expressed in 90% of NB tumors. The exclusive accumulation of MIBG in neuroblastoma has been widely studied; however, its properties have been never exploited as a targeting agent in nanocarrier drug delivery systems. Several structural analogues of MIBG have been prepared and attached on the surface of nanocarriers. Their selective internalization has been tested against human neuroblastoma cells, which show, in the best case, cellular uptake four times higher than that of the naked nanosystem. Furthermore, in vivo experiments showed preferential and selective accumulation and retention of the targeted nanosystem comparing with the naked and only PEGylated counterpart systems. This novel nanosystem could be easily applicable to all kinds of drug delivery nanocarriers, providing a universal tool for neuroblastoma chemotherapies that is superior to classical approaches through a novel nanosystem exclusively designed to target this terrible malignancy.

A GENERAL PROCEDURE FOR MILD AND RAPID REDUCTION OF ALIPHATIC AND AROMATIC NITRO COMPOUNDS USING AMMONIUM FORMATE AS A CATALYTIC HYDROGEN TRANSFER AGENT

Various aliphatic and aromatic nitro compounds were selectively and rapidly reduced to their corresponding amino derivatives in very good yield using anhydrous ammonium formate as a catalytic hydrogen transfer agent.